SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-11-072055
Filing Date
2011-03-21
Accepted
2011-03-21 11:34:51
Documents
1
Group Members
MVM (GP) (NO. 2) LIMITEDMVM EXECUTIVE LIMITEDMVM LIFE SCIENCE PARTNERS LLP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 116242
  Complete submission text file 0001193125-11-072055.txt   117950
Mailing Address 6 HENRIETTA STREET LONDON X0 WC2E8PIU
Business Address 6 HENRIETTA STREET LONDON X0 WC2E8PIU 44-2075577517
MVM International Life Sciences Fund No 1 L P (Filed by) CIK: 0001296587 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85739 | Film No.: 11700274
SIC: 2834 Pharmaceutical Preparations